Page 89 - JSOM Spring 2023

12. Luft A, Corcostegui SP, Millet M, et al. Aeromedical evacuations 16. Corrigan M, Wilson SS, Hampton J. Safety and efficacy of intra-
within the French Armed Forces: Analysis of 2,129 patients. Mil nasally administered medications in the emergency department
Med. 2020;185(3-4):468–476. and prehospital settings. Am J Health Syst Pharm. 2015;72(18):
13. Dubecq C, Taton P, Morand G. Intérêt de la kétamine intra nasale 1544–54.
dans le traitement de la douleur aiguë du blessé traumatique. Méd 17. Shrestha R, Pant S, Shrestha A, et al. Intranasal ketamine for the
Armées. 2018;46:143–50. treatment of patients with acute pain in the emergency depart-
14. Yanagihara Y, Ohtani M, Kariya S, et al. Plasma concentration ment. World J Emerg Med. 2016;7(1):19–24.
profiles of ketamine and norketamine after administration of var- 18. Andolfatto G, Willman E, Joo D, et al. Intranasal ketamine for an-
ious ketamine preparations to healthy Japanese volunteers. Bio- algesia in the emergency department: a prospective observational
pharm Drug Dispos. 2003;24:37–43. series. Acad Emerg Med. 2013 Oct;20(10):1050–4
15. Weber F, Wulf H, Gruber M, et al. S-Ketamine and S-norketamine 19. Jacques JM. Utilisation de la voie intranasale en médecine d’ur-
plasma concentrations after nasal and IV administration in anes- gence. Louvain Med. 2016;135:223–30
thetized children. Paediatr Anaesth. 2004;14:983–88. 20. Pasquier P, Bazin S, Petit L. The French syrette of morphine for
administration to combat casualties. Br J Pain. 2016;10:66.

Intranasal Ketamine for Prehospital Analgesia | 87